Literature DB >> 24998280

Etiology of valvular heart disease-genetic and developmental origins.

Joy Lincoln1, Vidu Garg.   

Abstract

Valvular heart disease occurs as either a congenital or acquired condition and advances in medical care have resulted in valve disease becoming increasingly prevalent. Unfortunately, treatments remain inadequate because of our limited understanding of the genetic and molecular etiology of diseases affecting the heart valves. Therefore, surgical repair or replacement remains the most effective option, which comes with additional complications and no guarantee of life-long success. Over the past decade, there have been significant advances in our understanding of cardiac valve development and, not surprisingly, mutations in these developmental genes have been identified in humans with congenital valve malformations. Concurrently, there has been a greater realization that acquired valve disease is not simply a degenerative process. Molecular investigation of acquired valve disease has identified that numerous signaling pathways critical for normal valve development are re-expressed in diseased valves. This review will discuss recent advances in our understanding of the development of the heart valves, as well as the implications of these findings on the genetics of congenital and acquired valvular heart disease.

Entities:  

Mesh:

Year:  2014        PMID: 24998280      PMCID: PMC7313685          DOI: 10.1253/circj.cj-14-0510

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  74 in total

1.  Loss of Gata5 in mice leads to bicuspid aortic valve.

Authors:  Brigitte Laforest; Gregor Andelfinger; Mona Nemer
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression.

Authors:  A Cano; M A Pérez-Moreno; I Rodrigo; A Locascio; M J Blanco; M G del Barrio; F Portillo; M A Nieto
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

3.  Genome-wide linkage mapping for valve calcification susceptibility loci in hypertensive sibships: the Hypertension Genetic Epidemiology Network Study.

Authors:  Jonathan N Bella; Weihong Tang; Aldi Kraja; Dabeeru C Rao; Steven C Hunt; Michael B Miller; Vittorio Palmieri; Mary J Roman; Dalane W Kitzman; Albert Oberman; Richard B Devereux; Donna K Arnett
Journal:  Hypertension       Date:  2007-01-15       Impact factor: 10.190

Review 4.  Coordinating tissue interactions: Notch signaling in cardiac development and disease.

Authors:  José Luis de la Pompa; Jonathan A Epstein
Journal:  Dev Cell       Date:  2012-02-14       Impact factor: 12.270

5.  VEGF signaling has distinct spatiotemporal roles during heart valve development.

Authors:  Kryn Stankunas; Gene K Ma; Frank J Kuhnert; Calvin J Kuo; Ching-Pin Chang
Journal:  Dev Biol       Date:  2010-09-15       Impact factor: 3.582

6.  Tgfβ-Smad and MAPK signaling mediate scleraxis and proteoglycan expression in heart valves.

Authors:  Damien N Barnette; Alexia Hulin; A S Ishtiaq Ahmed; Alain C Colige; Mohamad Azhar; Joy Lincoln
Journal:  J Mol Cell Cardiol       Date:  2013-10-21       Impact factor: 5.000

7.  Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.

Authors:  Jennifer P Habashi; Daniel P Judge; Tammy M Holm; Ronald D Cohn; Bart L Loeys; Timothy K Cooper; Loretha Myers; Erin C Klein; Guosheng Liu; Carla Calvi; Megan Podowski; Enid R Neptune; Marc K Halushka; Djahida Bedja; Kathleen Gabrielson; Daniel B Rifkin; Luca Carta; Francesco Ramirez; David L Huso; Harry C Dietz
Journal:  Science       Date:  2006-04-07       Impact factor: 47.728

8.  Developmental basis for filamin-A-associated myxomatous mitral valve disease.

Authors:  Kimberly Sauls; Annemarieke de Vlaming; Brett S Harris; Katherine Williams; Andy Wessels; Robert A Levine; Susan A Slaugenhaupt; Richard L Goodwin; Luigi Michele Pavone; Jean Merot; Jean-Jacques Schott; Thierry Le Tourneau; Thomas Dix; Sean Jesinkey; Yuanyi Feng; Christopher Walsh; Bin Zhou; Scott Baldwin; Roger R Markwald; Russell A Norris
Journal:  Cardiovasc Res       Date:  2012-07-25       Impact factor: 10.787

9.  Early experiences of transcatheter aortic valve replacement in Japan.

Authors:  Koichi Maeda; Toru Kuratani; Isamu Mizote; Kazuo Shimamura; Yasuharu Takeda; Kei Torikai; Satoshi Nakatani; Shinsuke Nanto; Yoshiki Sawa
Journal:  Circ J       Date:  2012-10-13       Impact factor: 2.993

10.  Sox9 transcriptionally represses Spp1 to prevent matrix mineralization in maturing heart valves and chondrocytes.

Authors:  Jacqueline D Peacock; Danielle J Huk; Hasini N Ediriweera; Joy Lincoln
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

View more
  20 in total

1.  Aortic regurgitation and heart valve disease in mice.

Authors:  Yong Fen Qi
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

2.  Genetic basis of aortic valvular disease.

Authors:  Sara N Koenig; Joy Lincoln; Vidu Garg
Journal:  Curr Opin Cardiol       Date:  2017-05       Impact factor: 2.161

3.  Increased canonical WNT/β-catenin signalling and myxomatous valve disease.

Authors:  Sunita Chopra; Nadia Al-Sammarraie; Yimu Lai; Mohamad Azhar
Journal:  Cardiovasc Res       Date:  2017-01       Impact factor: 10.787

4.  Spatiotemporal Complexity of the Aortic Sinus Vortex as a Function of Leaflet Calcification.

Authors:  Hoda Hatoum; Lakshmi Prasad Dasi
Journal:  Ann Biomed Eng       Date:  2019-02-01       Impact factor: 3.934

5.  Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.

Authors:  Andrew J Kim; Na Xu; Kazuhiro Umeyama; Alexia Hulin; Sithara Raju Ponny; Ronald J Vagnozzi; Ellis A Green; Paul Hanson; Bruce M McManus; Hiroshi Nagashima; Katherine E Yutzey
Journal:  Circulation       Date:  2020-01-13       Impact factor: 29.690

6.  Physiology of Cardiac Development: From Genetics to Signaling to Therapeutic Strategies.

Authors:  Cheng Sun; Maria I Kontaridis
Journal:  Curr Opin Physiol       Date:  2017-12-13

7.  BMP2 expression in the endocardial lineage is required for AV endocardial cushion maturation and remodeling.

Authors:  Jacob G Saxon; Daniel R Baer; Julie A Barton; Travis Hawkins; Bingruo Wu; Thomas C Trusk; Stephen E Harris; Bin Zhou; Yuji Mishina; Yukiko Sugi
Journal:  Dev Biol       Date:  2017-08-06       Impact factor: 3.582

8.  Valve Endothelial Cell-Derived Tgfβ1 Signaling Promotes Nuclear Localization of Sox9 in Interstitial Cells Associated With Attenuated Calcification.

Authors:  Danielle J Huk; Blair F Austin; Tori E Horne; Robert B Hinton; William C Ray; Donald D Heistad; Joy Lincoln
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-12-03       Impact factor: 8.311

9.  Mesenchymal TNFR2 promotes the development of polyarthritis and comorbid heart valve stenosis.

Authors:  Maria Sakkou; Panagiotis Chouvardas; Lydia Ntari; Alejandro Prados; Kristin Moreth; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabe de Angelis; Maria C Denis; Niki Karagianni; George Kollias
Journal:  JCI Insight       Date:  2018-04-05

Review 10.  Learn from Your Elders: Developmental Biology Lessons to Guide Maturation of Stem Cell-Derived Cardiomyocytes.

Authors:  Silvia Marchianò; Alessandro Bertero; Charles E Murry
Journal:  Pediatr Cardiol       Date:  2019-08-06       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.